The UK agency declined to recommend NHS funding for Spravato (esketamine) nasal spray in 2020 – following its approval as an add-on therapy for people with serious depression who don’t respond ...

So the initial discussions centered around, "Look, we think this is a good ... the antidepressant this week and it's a nasal spray. Speaker 10: Spravato is the first new type of depression ...

Johnson & Johnson has filed for FDA approval of its antidepressant nasal spray Spravato, hoping to make ... in a statement on the filing. And they "look forward to working with the FDA to bring ...

The remaining 20% is their coinsurance. S-ketamine, or esketamine (Spravato), is an FDA-approved nasal spray that doctors and healthcare professionals may prescribe for major depressive disorder ...

They may discuss switching to a different treatment besides Lamictal or Spravato. Your doctor can give you more information. Is it safe to use a nasal corticosteroid or decongestant during ...

I look forward to partnering with you ... or may have an increased risk of side effects. Esketamine/Spravato is the only FDA-approved nasal spray for adults with major depressive disorder who ...